Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.

Abstract:

:Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation frequency rates of known tumor suppressor genes in RCC are generally low, but the number of genes found to show frequent inactivation by promoter methylation in RCC continues to grow. Here, we review the genes identified as epigenetically silenced in RCC and their relationship to pathways of tumor development. Increased understanding of RCC epigenetics provides new insights into the molecular pathogenesis of RCC and opportunities for developing novel strategies for the diagnosis, prognosis and management of RCC.

journal_name

Genome Med

journal_title

Genome medicine

authors

Morris MR,Maher ER

doi

10.1186/gm180

subject

Has Abstract

pub_date

2010-09-03 00:00:00

pages

59

issue

9

issn

1756-994X

pii

gm180

journal_volume

2

pub_type

杂志文章
  • Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model.

    abstract::The zebrafish model is rapidly gaining prominence in the study of development, hematopoiesis, and disease. The zebrafish provides distinct advantages over other vertebrate models during early embryonic development by producing transparent, externally fertilized embryos. Embryonic zebrafish are easily visualized and ma...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm299

    authors: Martin CS,Moriyama A,Zon LI

    更新日期:2011-12-29 00:00:00

  • Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

    abstract:BACKGROUND:Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been ...

    journal_title:Genome medicine

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13073-019-0686-y

    authors: Lever J,Jones MR,Danos AM,Krysiak K,Bonakdar M,Grewal JK,Culibrk L,Griffith OL,Griffith M,Jones SJM

    更新日期:2019-12-03 00:00:00

  • The three-body problem of therapy with induced pluripotent stem cells.

    abstract::Regenerative medicine has a three-body problem: alignment of the dynamics of the genome, stem cell and patient. Focusing on the rare inherited fragile skin disorder epidermolysis bullosa, three recent innovative studies have used induced pluripotent stem cells and gene correction, revertant mosaicism or genome editing...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0141-7

    authors: Tolar J,McGrath JA

    更新日期:2015-02-20 00:00:00

  • DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.

    abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00794-7

    authors: Keller M,Yaskolka Meir A,Bernhart SH,Gepner Y,Shelef I,Schwarzfuchs D,Tsaban G,Zelicha H,Hopp L,Müller L,Rohde K,Böttcher Y,Stadler PF,Stumvoll M,Blüher M,Kovacs P,Shai I

    更新日期:2020-11-16 00:00:00

  • DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.

    abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0443-z

    authors: Simmonds P,Loomis E,Curry E

    更新日期:2017-06-07 00:00:00

  • Bridging the gap between systems biology and medicine.

    abstract::Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a tr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm88

    authors: Clermont G,Auffray C,Moreau Y,Rocke DM,Dalevi D,Dubhashi D,Marshall DR,Raasch P,Dehne F,Provero P,Tegner J,Aronow BJ,Langston MA,Benson M

    更新日期:2009-09-29 00:00:00

  • Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.

    abstract:BACKGROUND:Alzheimer's disease affects ~13% of people in the United States 65 years and older, making it the most common neurodegenerative disorder. Recent work has identified roles for environmental, genetic, and epigenetic factors in Alzheimer's disease risk. METHODS:We performed a genome-wide screen of DNA methylat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0258-8

    authors: Watson CT,Roussos P,Garg P,Ho DJ,Azam N,Katsel PL,Haroutunian V,Sharp AJ

    更新日期:2016-01-19 00:00:00

  • Actionable gene-based classification toward precision medicine in gastric cancer.

    abstract:BACKGROUND:Intertumoral heterogeneity represents a significant hurdle to identifying optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC patients, an actionable gene alteration-based molecular classification that directly associates GCs with targeted therapies is needed. METHODS:A...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0484-3

    authors: Ichikawa H,Nagahashi M,Shimada Y,Hanyu T,Ishikawa T,Kameyama H,Kobayashi T,Sakata J,Yabusaki H,Nakagawa S,Sato N,Hirata Y,Kitagawa Y,Tanahashi T,Yoshida K,Nakanishi R,Oki E,Vuzman D,Lyle S,Takabe K,Ling Y,Okuda

    更新日期:2017-10-31 00:00:00

  • Precision cancer mouse models through genome editing with CRISPR-Cas9.

    abstract::The cancer genome is highly complex, with hundreds of point mutations, translocations, and chromosome gains and losses per tumor. To understand the effects of these alterations, precise models are needed. Traditional approaches to the construction of mouse models are time-consuming and laborious, requiring manipulatio...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-015-0178-7

    authors: Mou H,Kennedy Z,Anderson DG,Yin H,Xue W

    更新日期:2015-06-09 00:00:00

  • Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe.

    abstract:BACKGROUND:Expression quantitative trait loci (eQTL) analysis is a powerful method to detect correlations between gene expression and genomic variants and is widely used to interpret the biological mechanism underlying identified genome wide association studies (GWAS) risk loci. Numerous eQTL studies have been performe...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-016-0320-1

    authors: Blauwendraat C,Francescatto M,Gibbs JR,Jansen IE,Simón-Sánchez J,Hernandez DG,Dillman AA,Singleton AB,Cookson MR,Rizzu P,Heutink P

    更新日期:2016-06-10 00:00:00

  • Prenatal diagnosis of fetal aneuploidies: post-genomic developments.

    abstract::Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies th...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm171

    authors: Hahn S,Jackson LG,Zimmermann BG

    更新日期:2010-08-05 00:00:00

  • Open science versus commercialization: a modern research conflict?

    abstract:BACKGROUND:Efforts to improve research outcomes have resulted in genomic researchers being confronted with complex and seemingly contradictory instructions about how to perform their tasks. Over the past decade, there has been increasing pressure on university researchers to commercialize their work. Concurrently, they...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm316

    authors: Caulfield T,Harmon SH,Joly Y

    更新日期:2012-02-27 00:00:00

  • Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.

    abstract:BACKGROUND:Based on promising phase II data, the histone deacetylase inhibitor entinostat is in phase III trials for patients with metastatic estrogen receptor-positive breast cancer. Predictors of sensitivity and resistance, however, remain unknown. METHODS:A total of eight cell lines and nine mouse models of breast ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0597-3

    authors: Tanioka M,Mott KR,Hollern DP,Fan C,Darr DB,Perou CM

    更新日期:2018-11-30 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • Haploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring.

    abstract:BACKGROUND:The HHIP gene, encoding Hedgehog interacting protein, has been implicated in chronic obstructive pulmonary disease (COPD) by genome-wide association studies (GWAS), and our subsequent studies identified a functional upstream genetic variant that decreased HHIP transcription. However, little is known about ho...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0137-3

    authors: Lao T,Glass K,Qiu W,Polverino F,Gupta K,Morrow J,Mancini JD,Vuong L,Perrella MA,Hersh CP,Owen CA,Quackenbush J,Yuan GC,Silverman EK,Zhou X

    更新日期:2015-02-14 00:00:00

  • Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.

    abstract:BACKGROUND:Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approa...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0407-3

    authors: Duffy DJ,Krstic A,Halasz M,Schwarzl T,Konietzny A,Iljin K,Higgins DG,Kolch W

    更新日期:2017-02-10 00:00:00

  • Estimating exome genotyping accuracy by comparing to data from large scale sequencing projects.

    abstract::With exome sequencing becoming a tool for mutation detection in routine diagnostics there is an increasing need for platform-independent methods of quality control. We present a genotype-weighted metric that allows comparison of all the variant calls of an exome to a high-quality reference dataset of an ethnically mat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm473

    authors: Heinrich V,Kamphans T,Stange J,Parkhomchuk D,Hecht J,Dickhaus T,Robinson PN,Krawitz PM

    更新日期:2013-07-31 00:00:00

  • Predicting cancer type from tumour DNA signatures.

    abstract:BACKGROUND:Establishing the cancer type and site of origin is important in determining the most appropriate course of treatment for cancer patients. Patients with cancer of unknown primary, where the site of origin cannot be established from an examination of the metastatic cancer cells, typically have poor survival. H...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-017-0493-2

    authors: Soh KP,Szczurek E,Sakoparnig T,Beerenwinkel N

    更新日期:2017-11-28 00:00:00

  • Microbiome mediation of infections in the cancer setting.

    abstract::Infections encountered in the cancer setting may arise from intensive cancer treatments or may result from the cancer itself, leading to risk of infections through immune compromise, disruption of anatomic barriers, and exposure to nosocomial (hospital-acquired) pathogens. Consequently, cancer-related infections are u...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-016-0306-z

    authors: Taur Y,Pamer EG

    更新日期:2016-04-18 00:00:00

  • Huntington's disease: the case for genetic modifiers.

    abstract::For almost three decades, Huntington's disease has been a prototype for the application of genetic strategies to human disease. HD, the Huntington's disease gene, was the first autosomal defect mapped using only DNA markers, a finding in 1983 that helped to spur similar studies in many other disorders and contributed ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm80

    authors: Gusella JF,MacDonald ME

    更新日期:2009-08-21 00:00:00

  • NARD: whole-genome reference panel of 1779 Northeast Asians improves imputation accuracy of rare and low-frequency variants.

    abstract::Here, we present the Northeast Asian Reference Database (NARD), including whole-genome sequencing data of 1779 individuals from Korea, Mongolia, Japan, China, and Hong Kong. NARD provides the genetic diversity of Korean (n = 850) and Mongolian (n = 384) ancestries that were not present in the 1000 Genomes Project Phas...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-019-0677-z

    authors: Yoo SK,Kim CU,Kim HL,Kim S,Shin JY,Kim N,Yang JSW,Lo KW,Cho B,Matsuda F,Schuster SC,Kim C,Kim JI,Seo JS

    更新日期:2019-10-22 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title:Genome medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13073-018-0601-y

    authors: Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期:2018-11-29 00:00:00

  • Clinical laboratory test-wide association scan of polygenic scores identifies biomarkers of complex disease.

    abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00820-8

    authors: Dennis JK,Sealock JM,Straub P,Lee YH,Hucks D,Actkins K,Faucon A,Feng YA,Ge T,Goleva SB,Niarchou M,Singh K,Morley T,Smoller JW,Ruderfer DM,Mosley JD,Chen G,Davis LK

    更新日期:2021-01-13 00:00:00

  • Enabling multiplexed testing of pooled donor cells through whole-genome sequencing.

    abstract::We describe a method that enables the multiplex screening of a pool of many different donor cell lines. Our method accurately predicts each donor proportion from the pool without requiring the use of unique DNA barcodes as markers of donor identity. Instead, we take advantage of common single nucleotide polymorphisms,...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0541-6

    authors: Chan Y,Chan YK,Goodman DB,Guo X,Chavez A,Lim ET,Church GM

    更新日期:2018-04-19 00:00:00

  • A phylogeny-based sampling strategy and power calculator informs genome-wide associations study design for microbial pathogens.

    abstract::Whole genome sequencing is increasingly used to study phenotypic variation among infectious pathogens and to evaluate their relative transmissibility, virulence, and immunogenicity. To date, relatively little has been published on how and how many pathogen strains should be selected for studies associating phenotype a...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0101-7

    authors: Farhat MR,Shapiro BJ,Sheppard SK,Colijn C,Murray M

    更新日期:2014-11-15 00:00:00

  • Sharing knowledge: a new frontier for public-private partnerships in medicine.

    abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm29

    authors: Auffray C

    更新日期:2009-03-04 00:00:00

  • Pharmacogenomics of adverse drug reactions.

    abstract::Considerable progress has been made in identifying genetic risk factors for idiosyncratic adverse drug reactions in the past 30 years. These reactions can affect various tissues and organs, including liver, skin, muscle and heart, in a drug-dependent manner. Using both candidate gene and genome-wide association studie...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm409

    authors: Daly AK

    更新日期:2013-01-29 00:00:00

  • NGS-Logistics: federated analysis of NGS sequence variants across multiple locations.

    abstract::As many personal genomes are being sequenced, collaborative analysis of those genomes has become essential. However, analysis of personal genomic data raises important privacy and confidentiality issues. We propose a methodology for federated analysis of sequence variants from personal genomes. Specific base-pair posi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0071-9

    authors: Ardeshirdavani A,Souche E,Dehaspe L,Van Houdt J,Vermeesch JR,Moreau Y

    更新日期:2014-09-17 00:00:00

  • Genetic and epigenetic insights into fetal alcohol spectrum disorders.

    abstract::The magnitude of the detrimental effects following in utero alcohol exposure, including fetal alcohol syndrome and other fetal alcohol spectrum disorders (FASD), is globally underestimated. The effects include irreversible cognitive and behavioral disabilities as a result of abnormal brain development, pre- and postna...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm148

    authors: Ramsay M

    更新日期:2010-04-28 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm547

    authors: Settleman J

    更新日期:2014-04-28 00:00:00